Shionogi & Co., Ltd. (TYO:4507)
3,012.00
+23.00 (0.77%)
Oct 30, 2026, 3:30 PM JST
Shionogi & Employees
Shionogi & had 6,223 employees as of March 31, 2026. The number of employees increased by 1,268 or 25.59% compared to the previous year. That makes Shionogi & the 4,827th largest employer in the world and 454th in Japan.
Employees
6,223
Change (1Y)
1,268
Growth (1Y)
25.59%
Revenue / Employee
90.50M JPY
Profits / Employee
42.34M JPY
Market Cap
2.56T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 6,223 | 1,268 | 25.59% |
| Mar 31, 2025 | 4,955 | -4 | -0.08% |
| Mar 31, 2024 | 4,959 | -721 | -12.69% |
| Mar 31, 2023 | 5,680 | -13 | -0.23% |
| Mar 31, 2022 | 5,693 | 208 | 3.79% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,029 |
| Eisai | 10,543 |
| Sumitomo Pharma | 4,980 |
| Tsumura & Co. | 4,923 |
| Towa Pharmaceutical | 4,923 |
| Sawai Group Holdings | 3,630 |
| Nippon Shinyaku | 2,309 |
| Kissei Pharmaceutical | 1,786 |
Shionogi & News
- 20 hours ago - Shionogi & Quarterly report: Q2 2027 - Filings
- 20 hours ago - Shionogi & Slides: Q2 2027 - Filings
- 1 day ago - Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Q2 Earnings Lag Estimates - Nasdaq
- 9 days ago - IDWeek 2026: Shionogi Presents U.S. Analysis of Real-World Data Showing Early Treatment Initiation with Fetroja®/Fetcroja® (cefiderocol) Improved Clinical Outcomes in Patients with Respiratory Infections - Business Wire
- 25 days ago - Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc. - Business Wire
- 25 days ago - Shionogi to Acquire IntraBio for $2 Billion - WSJ
- 7 weeks ago - Shionogi to Showcase Advancements Across its Infectious Disease Portfolio at IDWeek 2026 - Business Wire
- 2 months ago - Shionogi Announces U.S. Government Procurement of Fetroja® (cefiderocol) Through BARDA's Project BioShield to Support National Preparedness for Drug-Resistant Bacterial Threats - Business Wire